Celestica (CLS)
(Delayed Data from NYSE)
$52.67 USD
+1.60 (3.13%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $52.67 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
A Value A Growth A Momentum A VGM
Price, Consensus and EPS Surprise
CLS 52.67 +1.60(3.13%)
Will CLS be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for CLS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CLS
Celestica (CLS) Beats Q2 Earnings and Revenue Estimates
Celestica (CLS) is an Incredible Growth Stock: 3 Reasons Why
CLS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Celestica (CLS) Stock Outpacing Its Computer and Technology Peers This Year?
Despite Fast-paced Momentum, Celestica (CLS) Is Still a Bargain Stock
Is Schwab Fundamental International Small Company Index ETF (FNDC) a Strong ETF Right Now?
Other News for CLS
CIBC Reaffirms Their Hold Rating on Celestica (CLS)
Celestica price target raised by $2 at CIBC, here's why
Buy Rating Affirmed: Celestica’s Strong Q2 Financials and Positive Market Positioning
Celestica price target raised by $7 at Stifel, here's why
Celestica price target raised by $17 at Canaccord, here's why